# Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine

> **NCT00890422** · PHASE2 · UNKNOWN · sponsor: **Elisabethinen Hospital** · enrollment: 99 (estimated)

## Conditions studied

- Tick Borne Encephalitis

## Interventions

- **BIOLOGICAL:** FSME vaccination (FSME-Immun)

## Key facts

- **NCT ID:** NCT00890422
- **Lead sponsor:** Elisabethinen Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-03
- **Primary completion:** 2009-11
- **Final completion:** 2010-07
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2009-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00890422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00890422, "Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine". Retrieved via MORVS 2026-10-19 from https://api.morvs.ai/clinical/NCT00890422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*